StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.54−0.50 (-5.53%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

Benitec Biopharma profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Benitec Biopharma's profit margin for the twelve months ending Mar 31, 2024 was -309885.7%. For fiscal 2023 it was -26082.7%, against -24942.5% the year before. The highest annual figure on record is 21.4% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Jun 30, 2023-26082.7%−1140.2
FY2022Jun 30, 2022-24942.5%−1413.7
FY2021Jun 30, 2021-23528.8%−15417.0
FY2020Jun 30, 2020-8111.8%−8133.2
FY2019Jun 30, 201921.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2023CQ2 2023Jun 30, 2023-66585.7%−47301.7
Q3 FY2023CQ1 2023Mar 31, 2023-8142.6%+192007.4
Q2 FY2023CQ4 2022Dec 31, 2022-38650.0%+352250.0
Q3 FY2022CQ1 2022Mar 31, 2022-6822.9%+318377.1
Q2 FY2022CQ4 2021Dec 31, 2021-19284.0%−14342.2
Q4 FY2021CQ2 2021Jun 30, 2021-200150.0%−192642.9
Q3 FY2021CQ1 2021Mar 31, 2021-390900.0%−388185.7
Q2 FY2021CQ4 2020Dec 31, 2020-325200.0%−321724.2
Q1 FY2021CQ3 2020Sep 30, 2020-4941.8%–
Q3 FY2020CQ1 2020Mar 31, 2020-7507.1%–
Q2 FY2020CQ4 2019Dec 31, 2019-2714.3%–
Q1 FY2020CQ3 2019Sep 30, 2019-3475.8%–

More Benitec Biopharma figures

See a number that looks wrong?